Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
ACTIVE_NOT_RECRUITING
Status
Conditions
- Hematologic Diseases
- Acute Leukemia in Remission
- Chronic Myelogenous Leukemia - Chronic Phase
- Chronic Myelogenous Leukemia, Accelerated Phase
- Chronic Myelogenous Leukemia, Blastic Phase
- Myelodysplastic Syndromes
- Mantle Cell Lymphoma
- Follicular Lymphoma
- Diffuse Large B Cell Lymphoma
- Non Hodgkin Lymphoma
- Graft Vs Host Disease
- Graft-versus-host-disease
Interventions
- DRUG: Vorinostat
- PROCEDURE: Blood and Marrow Transplant (BMT)
- DRUG: Tacrolimus (or cyclosporine)
- DRUG: Methotrexate
- DRUG: Mycophenolate Mofetil (MMF)
- DRUG: Cyclophosphamide
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
- [object Object]
- [object Object]